Schematic overview of diabetes-associated microvascular (retinopathy, nephropathy, and neuropathy) and macrovascular (cerebrovascular, coronary artery,

Slides:



Advertisements
Similar presentations
TIME TO ACT Type 2 diabetes, the metabolic syndrome and cardiovascular disease in Europe CONTENTS Section One: Background to type 2 diabetes, the metabolic.
Advertisements

Blood Pressure and Diabetes Colin M. Dayan University of Bristol/UBHT.
What to do when basal bolus therapy fails in Type 2 Diabetes [insert name] UKHMG00596a February 2012 Prescribing information can be found on the last slide.
BY Dr. Khaled Helmy Al Mahmora Chest Hospital BY Dr. Khaled Helmy Al Mahmora Chest Hospital Treatment Of Hypertension In Diabetes.
PAD Rehabilitation Toolkit A Guide for Healthcare Professionals Healthy Steps for Peripheral Artery Disease (PAD) Developed by AACVPR and the Vascular.
Screening for Type 1 and Type 2 Diabetes Chapter 4 Jean-Marie Ekoé, Zubin Punthakee, Thomas Ransom, Ally PH Prebtani, Ron Goldenberg Canadian Diabetes.
Disturbances of carbohydrate metabolism. Diabetes mellitus. The State Education Institution of Higher Professional Training The First Sechenov Moscow State.
Etiology Primary hypertension 95% of all cases Secondary hypertension – 5% of all cases – Chronic renal disease – most common White coat hypertension –
DM Dewasa EVA DECROLI. Problems Increased of prevalence Cronic complications ex. Diabetic Foot Problems Prevention, primer, secunder tertier.
Exercise Stress Testing for Patients with Diabetes  Based on recommendations by ADA, Native American Cardiology Program, American College of Sports Medicine,
Diabetes.. Definition. The term of diabetes describes several syndromes of abnormal carbohydrates metabolism that are characterized by hyperglycemia.
Canadian Diabetes Association Clinical Practice Guidelines Screening for the Presence of Coronary Artery Disease Chapter 23 Paul Poirier, Robert Dufour,
Canadian Diabetes Association 2013 Clinical Practice Guidelines Targets for Glycemic Control Chapter 8 S. Ali Imran, Rémi Rabasa-Lhoret, Stuart Ross.
Diabetic Microvascular Disease: The Role of Glycemic Control and the Impact on Public Health Robert E. Ratner, MD MedStar Research Institute Georgetown.
What does it mean to our patients? Presenter: CF Otieno Affiliation: Department of Clinical Medicine and Therapeutics,UoN & KNH-Medicine.
RCS 6080 Medical and Psychosocial Aspects of Rehabilitation Counseling Diabetes and PVD.
Clinical Issues in the Management of Non Communicable Diseases Dr Gyaneshwar Rao Colonial War Memorial Hospital Suva.
Adult Medical-Surgical Nursing
Adult Medical-Surgical Nursing Endocrine Module: Longterm Complications of Diabetes Mellitus.
Microvascular and Macrovascular Complications in Hispanic Americans.
MENU ΣΤΕΦΑΝΙΑΙΑ ΝΟΣΟΣ ΣΕ ΔΙΑΒΗΤΙΚΟΥΣ ΚΑΙ ΗΛΙΚΙΩΜΕΝΟΥΣ.
Diabetes Mellitus By Harvi & Manpreet. What Is It?  complex metabolic disorder  elevated blood glucose concentration  secondary to resistance to action.
PREOPERATIVE ASSESSMENT Diabetic patients. Preoperative assessment of diabetic patients When considering the diabetic patient for surgery it is essential.
Impact of Diabetes on Cardiovascular Risk C.Richard Conti M.D. MACC Oct 16,2004 GWICC Beijing, PRC.
The Vicious Cycle. International Diabetes Federation What Causes CVD in Diabetes? Atherosclerosis Hypertension AND Microangiopathy Neuropathy Damage to.
Overview of advanced glycation end-products (AGEs) Part 2
Senior 1 Nursing Students University of Texas at Arlington Beth Mullen, BSN, RN, CCM.
Date of download: 6/21/2016 Copyright © The American College of Cardiology. All rights reserved. From: Frequency and Practice-Level Variation in Inappropriate.
Acute Infections and Insulin Requirements In pre-diabetic individuals acute infections may induce a temporary state of diabetes requiring short-term insulin.
Stroke “the brain attack”. Stroke Caused when blood flow to the brain is cut off There is a blockage in the arteries. That part of the brain suffocates.
Medical Consequences of Obesity
Fig. 1. The cumulative incidence of diabetic complication in middle-age-onset and elderly-onset diabetes. (A) Cumulative incidence (%) of coronary revascularization.
Long term complications of Diabetes Mellitus
Figure 1 Decision tree model showing the three strategies for prevention and control of diabetes and hypertension. From: Is diabetes and hypertension screening.
Takotsubo-Like Myocardial Dysfunction in Ischemic Stroke
Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.
Volume 14, Issue 6, Pages (June 2017)
End point Patients >75 y with renal insufficiency
Macrovascular Complications Microvascular Complications
National Diabetes Strategy
Chapter 2: Pharmacological cholesterol-lowering treatment in adults
Schematic of traditional and non-traditional risk factors that account for the greatly increased risk of macrovascular disease in people with DKD. CRP,
Volume 14, Issue 6, Pages (June 2017)
Cardiovascular Disease and CKD: Core Curriculum 2010
Baseline Characteristics
Kaplan–Meier estimates of the incidence of first heart failure hospitalization during follow-up according to the statin category among patients with type.
A schematic representation of the effects of early intensive glycemic control in preventing initial microvascular complications and then macrovascular.
Recent Temporal Changes in Atherosclerotic Cardiovascular Diseases in Ontario: Clinical and Health Systems Impact  Jack V. Tu, MD, PhD, Anam M. Khan,
Prevalence of microvascular and macrovascular complications compared between cohort 1 and cohort 2 for subjects with type 2 (A, upper panel) and type 1.
Conceptual model of the natural history of diabetic kidney disease.
Effects of Pay-for-Performance on the Quality of Primary Care in England Mean Scores for Clinical Quality at the Practice Level for Aspects of Care for.
(A) Rate of achieving targets for glycated hemoglobin (HbA1c), blood pressure (BP), and lipids in all subjects and (B) prevalence of nephropathy, retinopathy,
Time to death from diabetes diagnosis for propensity-matched sample adjusted for age, gender, race, and other conditions. Time to death from diabetes diagnosis.
Flow chart of the cohort selection for the study
Sensitivity analysis: random-effects model of the risk of lower extremity amputation (LEA) in people with diabetes associated with depression compared.
Interaction of updated mean serial HbA1c and serum triglyceride levels with sensory peripheral neuropathy over 7 years in 151 type 2 diabetic participants.
Arterial plasma glucose level and peripheral GIR in conscious dogs during the basal (−40 to 0 min) and experimental (0–240 min) periods treated with vehicle.
Prevalence of clinically significant microvascular (green) and clinically significant macrovascular (yellow) disease alone and combined microvascular and.
Schematic summary of ROS signaling on coronary artery malformation in the offspring of pregestational diabetic mice. Schematic summary of ROS signaling.
Forefoot peak plantar pressure in diabetic patients without and with mild, moderate, and severe peripheral neuropathy. *Severe and moderate neuropathy.
Associations of body mass index (BMI) levels with achieving targets for glycated hemoglobin (HbA1c), blood pressure (BP), and lipids in the upper panels.
The effect of PAD and infection on outcome of cast treatment
Kaplan-Meier estimation of diabetes-related survival curves in patients grouped according to increased 24-h proteinuria (A), the presence of preexisting.
Concomitant cardiac and vascular disease: “Through the looking glass”
A: Incidences of all-cause mortality, coronary artery events, and cerebrovascular events by quartiles of baPWV during the follow-up period. A: Incidences.
Prevalence of nephropathy, retinopathy, and neuropathy in subjects achieving all (A) three targets, (B) two targets, (C) one target, and (D) none, and.
Predicted, unadjusted prevalence of aggregate MVD (retinopathy, nephropathy, and/or neuropathy) (A), nephropathy (B), retinopathy (C), and neuropathy (D)
Relationship between updated systolic blood pressure (SBP), right, and updated HbA1c, left, and the incidence of microvascular complications (closed symbols)
Mayo Clinic Proceedings
Volume 14, Issue 6, Pages (June 2017)
Presentation transcript:

Schematic overview of diabetes-associated microvascular (retinopathy, nephropathy, and neuropathy) and macrovascular (cerebrovascular, coronary artery, and peripheral arterial diseases) complications and their clinical long-term manifestations. Schematic overview of diabetes-associated microvascular (retinopathy, nephropathy, and neuropathy) and macrovascular (cerebrovascular, coronary artery, and peripheral arterial diseases) complications and their clinical long-term manifestations. TIA, transient ischemic attack. Joost C. van den Born et al. Diabetes 2016;65:331-345 ©2016 by American Diabetes Association